BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study

Raffaele Pellegrino, Gianluca Pellino, Lucio Selvaggi, Francesco Selvaggi, Alessandro Federico, Marco Romano, Antonietta Gerarda Gravina*

*Autor corresponent d’aquest treball

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

15 Cites (Scopus)

Fingerprint

Navegar pels temes de recerca de 'BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study'. Junts formen un fingerprint únic.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science